cas 445312-74-3|| where to buy (R)-2-tert-Butyl 8a-methyl 6-oxo-3,4,6,7,8,8a-hexahydroisoquinoline-2,8a(1H)-dicarboxylate

Nom du produit:(R)-2-tert-Butyl 8a-methyl 6-oxo-3,4,6,7,8,8a-hexahydroisoquinoline-2,8a(1H)-dicarboxylate

IUPAC Name:2-tert-butyl 8a-methyl (8aR)-6-oxo-1,2,3,4,6,7,8,8a-octahydroisoquinoline-2,8a-dicarboxylate

Unité d'emballage	Stock disponible	Prix($)	Quantité
CM229457-10g	in stock	ǙǪĲŮ

Pour une utilisation en R&D uniquement..

Formulaire de demande

Nom chimique

Numéro CAS

Quantité*

Spécifications requises*
(% d'analyse, qualité du matériau, etc.)

Nom du contact*

Email du contact*

Meanwhile I'd like to create a registered account on CHEMENU.COM with the above email.

I'd like to receive emails related to products with similar structures to 445312-74-3 regularly via the above email.

Notes supplémentaires

Verification code*

refresh

: N° CAS:445312-74-3; Formule moléculaire:C16H23NO5; Point de fusion:-; Code SMILES:O=C(N(CCC1=C2)C[C@@]1(C(OC)=O)CCC2=O)OC(C)(C)C; Densité:

: Numéro de catalogue:CM229457; Poids moléculaire:309.36; Point d'ébullition:; N° Mdl:; Stockage:

: Relacorilant; Corcept completes enrollment in phase 3 Gradient trial of Relacorilant in patients with Adrenal Cushing’s Syndrome. Cushing's disease or hypercortisolism is a rare endocrine disorder that occurs when a pituitary adenoma makes excessive cortisol. Cortisol exerts its functions by binding to the glucocorticoid receptor (GR).
Relacorilant is a selective glucocorticoid receptor modulator (SGRM) in clinical development to prevent the effects of high cortisol. Relacorilant is being studied in various serious disorders, including ovarian, adrenal and prostate cancer and Cushing’s syndrome.